Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

MSK1 activation in acute myeloid leukemia cells with FLT3 mutations

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Wadleigh M, DeAngelo DJ, Griffin JD, Stone RM . After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies. Blood 2005; 105: 22–30.

    Article  CAS  PubMed  Google Scholar 

  2. Stone RM, DeAngelo DJ, Klimek V, Galinsky I, Estey E, Nimer SD et al. Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. Blood 2005; 105: 54–60.

    Article  CAS  PubMed  Google Scholar 

  3. Thomson S, Clayton AL, Hazzalin CA, Rose S, Barratt MJ, Mahadevan LC . The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J 1999; 18: 4779–4793.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Furukawa Y, Vu HA, Akutsu M, Odgerel T, Izumi T, Tsunoda S et al. Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus negative leukemia cell lines. Leukemia 2007; 21: 1005–1014.

    Article  CAS  PubMed  Google Scholar 

  5. Kim H-G, Lee KW, Cho Y-Y, Kang NJ, Oh S-M, Bode AM et al. Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res 2008; 68: 2538–2547.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Srinivasa SP, Doshi PD . Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line. Leukemia 2002; 16: 244–253.

    Article  CAS  PubMed  Google Scholar 

  7. Parmar S, Katsoulidis E, Verma A, Li Y, Sassano A, Lal L et al. Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells. J Biol Chem 2004; 279: 25345–25352.

    Article  CAS  PubMed  Google Scholar 

  8. Dumka D, Puri P, Carayoi N, Balachandran H, Schuster K, Verma AK et al. Activation of the p38 MAP kinase pathway is essential for the antileukemic effects of dasatinib. Leuk Lymphoma 2009; 50: 2017–2029.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y Furukawa.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Odgerel, T., Kikuchi, J., Wada, T. et al. MSK1 activation in acute myeloid leukemia cells with FLT3 mutations. Leukemia 24, 1087–1090 (2010). https://doi.org/10.1038/leu.2010.48

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.48

This article is cited by

Search

Quick links